The Role of Catestatin in Preeclampsia
Preeclampsia (PE) is a unique pregnancy disorder affecting women across the world. It is characterized by the new onset of hypertension with coexisting end-organ damage. Although the disease has been known for centuries, its exact pathophysiology and, most importantly, its prevention remain elusive....
Main Authors: | Michalina Bralewska, Tadeusz Pietrucha, Agata Sakowicz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/25/5/2461 |
Similar Items
-
Reduction in CgA-Derived CST Protein Level in HTR-8/SVneo and BeWo Trophoblastic Cell Lines Caused by the Preeclamptic Environment
by: Michalina Bralewska, et al.
Published: (2023-04-01) -
Chromogranin A: An Endocrine Factor of Pregnancy
by: Michalina Bralewska, et al.
Published: (2023-03-01) -
Catestatin—A Potential New Therapeutic Target for Women with Preeclampsia? An Analysis of Maternal Serum Catestatin Levels in Preeclamptic Pregnancies
by: Pilar Palmrich, et al.
Published: (2023-09-01) -
Serum Catestatin Levels Correlate with Ambulatory Blood Pressure and Indices of Arterial Stiffness in Patients with Primary Hypertension
by: Marko Kumric, et al.
Published: (2022-08-01) -
Catestatin: Antimicrobial Functions and Potential Therapeutics
by: Suborno Jati, et al.
Published: (2023-05-01)